Ashurst has advised SYNthesis med chem Pty Limited on the deal. SYNthesis med chem Pty Limited, an Australian company, on sold its 100% equity interest in…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
